Published in J Hypertens on February 01, 2001
Sleep-disordered breathing in nondialyzed patients with chronic renal failure. Lung (2006) 1.22
Clinical presentation of obstructive sleep apnea in patients with end-stage renal disease. J Clin Sleep Med (2009) 0.99
Nocturnal hypoxemia and periodic limb movement predict mortality in patients on maintenance hemodialysis. Clin J Am Soc Nephrol (2010) 0.93
Diagnostic value of screening instruments for identifying obstructive sleep apnea in kidney failure. J Clin Sleep Med (2013) 0.88
Clinical presentation of obstructive sleep apnea in patients with chronic kidney disease. J Clin Sleep Med (2012) 0.85
Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology (2001) 6.55
Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain (2002) 4.05
Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain (2005) 3.99
Protein composition of the intranuclear inclusions of FXTAS. Brain (2005) 2.95
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet (2002) 2.92
Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. Am J Hum Genet (2004) 2.33
Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: a preliminary report. Am J Med Genet (1999) 2.26
Low triiodothyronine and survival in end-stage renal disease. Kidney Int (2006) 1.88
Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol (2001) 1.83
FMR1 CGG repeat length predicts motor dysfunction in premutation carriers. Neurology (2007) 1.80
Volumetric brain changes in females with fragile X-associated tremor/ataxia syndrome (FXTAS). Neurology (2007) 1.77
Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ataxia syndrome. J Med Genet (2004) 1.77
Reproducibility of the response to short-term low salt intake in essential hypertension. J Hypertens (1996) 1.76
Aging in individuals with the FMR1 mutation. Am J Ment Retard (2004) 1.68
Molecular and imaging correlates of the fragile X-associated tremor/ataxia syndrome. Neurology (2006) 1.55
Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients. J Am Soc Nephrol (2001) 1.54
Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol (2001) 1.46
Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome. Genes Brain Behav (2012) 1.41
Evidence for, and a spectrum of, neurological involvement in carriers of the fragile X pre-mutation: FXTAS and beyond. Clin Genet (2005) 1.37
Psychological symptoms correlate with reduced hippocampal volume in fragile X premutation carriers. Am J Med Genet B Neuropsychiatr Genet (2010) 1.14
Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients. Nephrol Dial Transplant (2001) 1.12
Fragile X-associated tremor/ataxia phenotype in a male carrier of unmethylated full mutation in the FMR1 gene. Clin Genet (2011) 1.08
Nocturnal hypoxemia, night-day arterial pressure changes and left ventricular geometry in dialysis patients. Kidney Int (1998) 1.07
Clinical involvement in daughters of men with fragile X-associated tremor ataxia syndrome. Clin Genet (2010) 1.04
Variability in FMRP and early development in males with fragile X syndrome. Am J Ment Retard (2001) 1.03
Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients. J Hypertens (2000) 1.01
Tissue heterogeneity of the FMR1 mutation in a high-functioning male with fragile X syndrome. Am J Med Genet (1999) 1.00
Fibrinogen, mortality and incident cardiovascular complications in end-stage renal failure. J Intern Med (2003) 0.99
Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int (2001) 0.99
Spastic paraparesis, cerebellar ataxia, and intention tremor: a severe variant of FXTAS? J Med Genet (2005) 0.98
Fragile X-associated tremor/ataxia syndrome (FXTAS) in grey zone carriers. Clin Genet (2012) 0.97
Endogenous ouabain and cardiomyopathy in dialysis patients. J Intern Med (2007) 0.97
AGEs and carbonyl stress: potential pathogenetic factors of long-term uraemic complications. Nephrol Dial Transplant (2000) 0.97
Effects of short-term administration of low-dose rhGH on IGF-I levels in obesity and Cushing's syndrome: indirect evaluation of sensitivity to GH. Eur J Endocrinol (2001) 0.94
FMR1 premutation in females diagnosed with multiple sclerosis. J Neurol Neurosurg Psychiatry (2009) 0.93
Prevalence and risk of migraine headaches in adult fragile X premutation carriers. Clin Genet (2013) 0.93
Adrenal responsiveness to high, low and very low ACTH 1-24 doses in obesity. Clin Endocrinol (Oxf) (2000) 0.92
Sleep apnea in renal patients. J Am Soc Nephrol (2001) 0.92
Prediction of left ventricular geometry by clinic, pre-dialysis and 24-h ambulatory BP monitoring in hemodialysis patients: CREED investigators. J Hypertens (1999) 0.91
Psychological status in female carriers of premutation FMR1 allele showing a complex relationship with the size of CGG expansion. Clin Genet (2014) 0.90
Tremor/ataxia syndrome and fragile X premutation: diagnostic caveats. J Clin Neurosci (2006) 0.89
FXTAS in an unmethylated mosaic male with fragile X syndrome from Chile. Clin Genet (2013) 0.89
Obese patients with obstructive sleep apnoea syndrome show a peculiar alteration of the corticotroph but not of the thyrotroph and lactotroph function. Clin Endocrinol (Oxf) (2004) 0.88
Waist circumference modifies the relationship between the adipose tissue cytokines leptin and adiponectin and all-cause and cardiovascular mortality in haemodialysis patients. J Intern Med (2010) 0.88
Autonomic neuropathy is linked to nocturnal hypoxaemia and to concentric hypertrophy and remodelling in dialysis patients. Nephrol Dial Transplant (2001) 0.88
Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure. Eur J Clin Invest (2003) 0.88
Circulating E-selectin as a risk marker in patients with end-stage renal disease. J Intern Med (2007) 0.88
Pericentric inversion of chromosome 9: prevalence in 300 Down syndrome families and molecular studies of nondisjunction. Am J Med Genet Suppl (1990) 0.87
Urinary adrenomedullin is related to ET-1 and salt intake in patients with mild essential hypertension. Salt Sensitivity Group of Italian Society of Hypertension. Am J Hypertens (2001) 0.87
Concomitant impairment of growth hormone secretion and peripheral sensitivity in obese patients with obstructive sleep apnea syndrome. J Clin Endocrinol Metab (2002) 0.87
A search for genes from the dark band regions of human chromosome 21. Genomics (1995) 0.87
Investigation of candidate genes for glycolytic potential of porcine skeletal muscle: Association with meat quality and production traits in Italian Large White pigs. Meat Sci (2008) 0.86
Analysis of pufferfish homologues of the AT-rich human APP gene. Gene (1998) 0.86
Urotensin II is an inverse predictor of incident cardiovascular events in end-stage renal disease. Kidney Int (2006) 0.86
Autonomic function in uremic patients treated by hemodialysis or CAPD and in transplant patients. Clin Nephrol (1986) 0.86
Renal endothelin-1 is linked to changes in urinary salt and volume in essential hypertension. Salt Sensitivity Group of the Italian Society of Hypertension. J Nephrol (2000) 0.86
Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients. Nutr Metab Cardiovasc Dis (2011) 0.86
Blood glucose pre-prandial baseline decreases from morning to evening in type 2 diabetes: role of fasting blood glucose and influence on post-prandial excursions. Eur J Clin Invest (2002) 0.85
Construction of a 2.5-Mb integrated physical and gene map of distal 21q22.3. Genomics (1998) 0.84
Adiponectin and renal disease progression: another epidemiologic conundrum? Kidney Int (2007) 0.84
[Duodenal phytobezoar in annular pancreas: an association or a complication?]. Radiol Med (1989) 0.83
Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency. Int J Obes Relat Metab Disord (2001) 0.83
Map location, genomic organization and expression patterns of the human RED1 RNA editase. Somat Cell Mol Genet (1997) 0.83
Sleep disordered breathing in renal transplant patients. Am J Transplant (2009) 0.83
Urinary and plasma endothelin 1 in essential hypertension and in hypertension secondary to renoparenchymal disease. Nephrol Dial Transplant (1995) 0.82
Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease. Am J Kidney Dis (2000) 0.81